Bivalirudin Versus Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Bivalirudin Versus Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention

Published:2015-01 Issue:1 Volume:65 Page:27-38
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Stone Gregg W.,Mehran Roxana,Goldstein Patrick,Witzenbichler Bernhard,van’t Hof Arnoud,Guagliumi Giulio,Hamm Christian W.,Généreux Philippe,Clemmensen Peter,Pocock Stuart J.,Gersh Bernard J.,Bernstein Debra,Deliargyris Efthymios N.,Steg Philippe Gabriel

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference38 articles.

1. Bivalirudin during primary PCI in acute myocardial infarction;Stone;N Engl J Med,2008

2. Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial;Stone;Lancet,2011

3. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction;Dangas;Circulation,2011

4. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial;Montalescot;Lancet,2009

5. Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: a Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis;Steg;Circulation,2010

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bivalirudin versus heparin in STEMI after BRIGHT-4 trial: an updated meta-analysis;Coronary Artery Disease;2023-09-20

2. Safety and Efficacy of Bivalirudin versus Unfractionated Heparin Monotherapy in Patients with CAD and DM Undergoing PCI: A Retrospective Observational Study;Cardiovascular Therapeutics;2022-11-30

3. Rationale and Design of a Randomized Controlled Trial of Bivalirudin with a Prolonged High-Dose Infusion Versus Heparin Monotherapy During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction: The BRIGHT-4 Trial;Cardiology Discovery;2022-08-23

4. The efficacy of the use of heparin in the emergency room in patients with acute ST-segment elevation myocardial infarction;Journal of Radiation Research and Applied Sciences;2022-03

5. Bivalirudin in Primary PCI: Can Its Glory Being Restored?;Cardiology Discovery;2021-04-06